Healthcare provider profile · identity verified

Wendy Day, MD

Internal Medicine · COLORADO SPRINGS, CO · NPI 1922074780

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	474	126
Atorvastatin Calcium	Atorvastatin Calcium	409	120
Rosuvastatin Calcium	Rosuvastatin Calcium	401	121
Lisinopril	Lisinopril	225	70
Omeprazole	Omeprazole	196	56
Losartan Potassium	Losartan Potassium	175	53
Amlodipine Besylate	Amlodipine Besylate	171	54
Gabapentin	Gabapentin	165	61
Metoprolol Succinate	Metoprolol Succinate	154	42
Trazodone Hcl	Trazodone Hcl	150	48
Alendronate Sodium	Alendronate Sodium	124	39
Metformin Hcl Er	Metformin Hcl	121	39
Zolpidem Tartrate	Zolpidem Tartrate	118	37
Pantoprazole Sodium	Pantoprazole Sodium	114	44
Simvastatin	Simvastatin	110	32
Bupropion Xl	Bupropion Hcl	97	27
Jardiance	Empagliflozin	91	28
Tramadol Hcl	Tramadol Hcl	86	23
Metformin Hcl	Metformin Hcl	79	25
Allopurinol	Allopurinol	77	24
Duloxetine Hcl	Duloxetine Hcl	76	26
Escitalopram Oxalate	Escitalopram Oxalate	73	20
Ezetimibe	Ezetimibe	73	21
Estradiol	Estradiol	70	25
Hydrochlorothiazide	Hydrochlorothiazide	70	24
Fluoxetine Hcl	Fluoxetine Hcl	69	22
Alprazolam	Alprazolam	68	21
Potassium Chloride	Potassium Chloride	68	20
Sertraline Hcl	Sertraline Hcl	67	27
Venlafaxine Hcl Er	Venlafaxine Hcl	67	15
Meloxicam	Meloxicam	64	27
Pravastatin Sodium	Pravastatin Sodium	62	19
Synthroid	Levothyroxine Sodium	58	16
Montelukast Sodium	Montelukast Sodium	57	18
Eliquis	Apixaban	52	12
Clonazepam	Clonazepam	51	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	18
Tamsulosin Hcl	Tamsulosin Hcl	44	17
Albuterol Sulfate Hfa	Albuterol Sulfate	43	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	40	17
Atenolol	Atenolol	39	suppressed
Furosemide	Furosemide	39	15
Mirtazapine	Mirtazapine	39	16
Famotidine	Famotidine	37	13
Ozempic	Semaglutide	37	suppressed
Spironolactone	Spironolactone	36	11
Lorazepam	Lorazepam	33	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	14
Fenofibrate	Fenofibrate	30	suppressed
Trulicity	Dulaglutide	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	13
Ibandronate Sodium	Ibandronate Sodium	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Solifenacin Succinate	Solifenacin Succinate	27	suppressed
Celecoxib	Celecoxib	25	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Torsemide	Torsemide	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	23	suppressed
Fluticasone Propionate	Fluticasone Propionate	23	suppressed
Prednisone	Prednisone	23	17
Xarelto	Rivaroxaban	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Premarin	Estrogens, Conjugated	22	suppressed
Fenofibrate	Fenofibrate,micronized	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	12
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Triazolam	Triazolam	21	suppressed
Bumetanide	Bumetanide	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	11
Ondansetron Odt	Ondansetron	19	11
Tizanidine Hcl	Tizanidine Hcl	19	12
Valsartan	Valsartan	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Armour Thyroid	Thyroid,pork	16	suppressed
Carvedilol	Carvedilol	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Scopolamine	Scopolamine	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	14
Nystatin	Nystatin	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Progesterone	Progesterone, Micronized	14	suppressed
Temazepam	Temazepam	14	suppressed
Topiramate	Topiramate	14	suppressed
Amoxicillin	Amoxicillin	13	11
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Finasteride	Finasteride	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Cardizem La	Diltiazem Hcl	12	suppressed
Dextroamphetamine Sulfate	Dextroamphetamine Sulfate	12	suppressed
Estradiol (Once Weekly)	Estradiol	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	12
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Linzess	Linaclotide	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error